🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06972225
Recruiting Observational

Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.

NCT06972225 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2025-06-10
Last updated
2026-04-20

Condition(s) studied

Coronary Arterial Disease (CAD)Restenosis, CoronaryBifurcation Coronary Disease

Investigational drug(s) / intervention(s)

DEB

DEB: Use of DEB to treat coronary lesions

Study summary

Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults (\>=18 years of age) * Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025 * Identified in the institutional procedure database Exclusion Criteria: * Incomplete or non-available data on the post-procedural clinical follow-up * Procedures where other devices were used in combination with drug-eluting balloons.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
IUCPQ Québec Quebec Recruiting

More Olivier F. Bertrand trials in Canada

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06972225 on ClinicalTrials.gov ↗ ← All trials in Canada